EZZ Life Science Holdings Limited (EZZ.AX)

1.0000 +0.0300 (+3.09%) At close: 01:44PM AEST

EZZ Life Science Holdings Limited

104 Derby Street
Silverwater, NSW 2128
Australia
61 2 9160 2305
https://ezzlife.com.au

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Mark Qin	Co-founder, COO, CEO & Executive Director	172.94k	N/A	N/A
Anthony Guarna	Chief Financial Officer	105.56k	N/A	N/A
Ms. Natalie Climo L.L.B.	Company Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.

Corporate Governance

EZZ Life Science Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.